Quote | C4 Therapeutics Inc. (NASDAQ:CCCC)
Last: | $5.68 |
---|---|
Change Percent: | -0.34% |
Open: | $5.99 |
Close: | $5.68 |
High: | $6.01 |
Low: | $5.62 |
Volume: | 1,255,076 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
News | C4 Therapeutics Inc. (NASDAQ:CCCC)
2024-05-08 13:54:22 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips C4 Therapeutics (NASDAQ: CCCC ) just reported results for the first quarter of 2024. C4 Therapeutics reported earnings per share of -41 cents. This was below the analyst e...
2024-05-08 11:26:56 ET C4 Therapeutics press release ( NASDAQ: CCCC ): Q1 GAAP EPS of -$0.41 in-line. Revenue of $3.04M (-19.1% Y/Y) misses by $6.24M . Cash, cash equivalents and marketable securities as of March 31, 2024 were $299.2 million, compared to $281.7 mil...
Message Board Posts | C4 Therapeutics Inc. (NASDAQ:CCCC)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
C4 Therapeutics Inc. Company Name:
CCCC Stock Symbol:
NASDAQ Market:
Successfully Delivered First Development Candidate to Biogen; $8 Million Payment Earned Established a Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Focused on Two Critical Oncogenic Proteins Progressed Phase 1 Dose Escalation Trials for Cemsidom...
2024-05-06 09:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...